Literature DB >> 21577313

Effect of anesthetics on gastric damage using two models of portal hypertension.

Paula Rs Câmara1, Gisele P Moi, José Geraldo P Ferraz, José Murilo R Zeitune.   

Abstract

AIM: To investigate the effect of sodium pentobarbitone (SP) or ketamine/xylazine (KX) anesthetics on acute gastric injury.
METHODS: Portal hypertension was induced by bile duct ligation (BDL) or portal vein stenosis (PVS). Ethanol (EtOH)-induced gastric damage was assessed using ex vivo gastric chamber experiments. Gastric blood flow (GBF) was also measured by laser doppler flowmetry.
RESULTS: EtOH-induced gastric damage was reduced in BDL rats under KX anesthesia in comparison to those under SP anesthesia. GBF dysfunction in fasted BDL rats was partially restored under KX anesthesia. In contrast, in fasted PVS rats, EtOH-induced gastric damage was increased under KX anesthesia while GBF was reduced.
CONCLUSION: The use of KX anesthesia in experimental procedures involving cirrhotic rats (but not those with pure portal hypertension) is preferable to SP anesthesia.

Entities:  

Keywords:  Cirrhosis; Gastric damage; Ketamine/xylazine; Portal hypertension; Sodium pentobarbitone

Year:  2010        PMID: 21577313      PMCID: PMC3091276          DOI: 10.4292/wjgpt.v1.i4.81

Source DB:  PubMed          Journal:  World J Gastrointest Pharmacol Ther        ISSN: 2150-5349


  44 in total

1.  Alpha 2-adrenergic modulation of pancreatic glucagon secretion in rats.

Authors:  M Saito; T Saitoh; S Inoue
Journal:  Physiol Behav       Date:  1992-06

2.  Central alpha2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia.

Authors:  A D Cabral; D R Kapusta; V A Kenigs; K J Varner
Journal:  Am J Physiol       Date:  1998-12

3.  Haemodynamic rebound phenomena after abrupt cessation of propranolol therapy in portal hypertensive rats.

Authors:  S S Lee; A Braillon; C Girod; P Geoffroy; D Lebrec
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

4.  Gastric distension-induced pyloric relaxation: central nervous system regulation and effects of acute hyperglycaemia in the rat.

Authors:  T Ishiguchi; M Nakajima; H Sone; H Tada; A K Kumagai; T Takahashi
Journal:  J Physiol       Date:  2001-06-15       Impact factor: 5.182

5.  Small artery and vein response to ketamine HCl in the bat wing.

Authors:  D E Longnecker; F N Miller; P D Harris
Journal:  Anesth Analg       Date:  1974 Jan-Feb       Impact factor: 5.108

6.  Tissue response to intramuscular and intraperitoneal injections of ketamine and xylazine in rats.

Authors:  K L Smiler; S Stein; K L Hrapkiewicz; J R Hiben
Journal:  Lab Anim Sci       Date:  1990-01

7.  Different effects of D-glucose anomers on enhanced motility of the stomach.

Authors:  T Sakaguchi; T Taguchi; J Okuda
Journal:  Biochem Int       Date:  1983-09

8.  The role of I(1)-imidazoline and alpha(2)-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X.

Authors:  Rodney A Velliquette; Paul Ernsberger
Journal:  J Pharmacol Exp Ther       Date:  2003-05-19       Impact factor: 4.030

9.  Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.

Authors:  Paula R S Camara; Gerson J N Ferraz; Carla F Franco-Penteado; Lourenco Sbragia-Neto; Luciana R Meirelles; Simone A Teixeira; Marcelo N Muscara; Licio A Velloso; Edson Antunes; Jose G P Ferraz
Journal:  Eur J Pharmacol       Date:  2008-05-16       Impact factor: 4.432

10.  Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres.

Authors:  M Chojkier; R J Groszmann
Journal:  Am J Physiol       Date:  1981-05
View more
  1 in total

1.  Endothelin and neonatal capsaicin regulate gastric resistance to injury in BDL rats.

Authors:  Paula Rs Câmara; Gerson Jn Ferraz; Licio A Velloso; José Murilo R Zeitune; Fernando Ab Suassuna; Jose Geraldo P Ferraz
Journal:  World J Gastrointest Pathophysiol       Date:  2012-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.